July 18, 2023 C-Path Integrates European Offices to Optimize Global Operations and Collaborative Partnerships AMSTERDAM and TUCSON, Ariz., July 18, 2023 — Critical Path Institute (C-Path) announced today the completion of the integration
July 13, 2023 C-Path and Vivpro Formalize Partnership to Accelerate Drug Development The strategic collaboration between C-Path and Vivpro seeks to leverage Vivpro’s innovative biointelligence platform, foster
July 13, 2023 Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey Between January and March 2022, WHO conducted a global online survey to collect data on diagnostic capacities and treatment...
July 13, 2023 Drug Repurposing for Pandemic Innovation: Establishing an Effective and Efficient Ecosystem Effective treatments for both existing and emerging diseases may already be available on pharmacy shelves. Many approved drugs...
July 12, 2023 Sanford Health Rare Disease Data Registry Partners with C-Path’s RDCA-DAP, Cure Mito Foundation to Aggregate Rare Disease Data in Platform TUCSON, Ariz., July 12, 2023 — Critical Path Institute (C-Path) announced today that the Coordination of Rare Diseases based at
July 6, 2023 Multistakeholder Collaborations Are Vital to Advancing Technologies in Parkinson’s TUCSON, Ariz., July 6, 2023 — Critical Path Institute (C-Path) and the Center for Health + Technology (CHeT) at University of Ro
July 6, 2023 Worldwide collaborative framework for optimizing new Parkinson’s treatment trials with patient centric outcome measures
June 28, 2023 C-Path’s TRxA Announces $750,000 in Research Awards to Accelerate its First Drug Development Projects TUCSON, Ariz., June 28, 2023 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) announced toda
June 25, 2023-June 29, 2023 DIA 2023 Global Annual Meeting | ILLUMINATE The DIA 2023 Global Annual Meeting invites industry, regulatory government, academics, and patients to network, problem-solve, and
